Effective testosterone suppression for patients with prostate cancer: is there a best castration?
- 1 August 2003
- Vol. 62 (2) , 207-213
- https://doi.org/10.1016/s0090-4295(03)00331-5
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Health Related Quality of Life Using Serum Testosterone as the Trigger to Re-Dose Long Acting Depot Luteinizing Hormone-Releasing Hormone Agonists in Patients with Prostate CancerJournal of Urology, 2003
- A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer First Report from the Scandinavian Prostatic Cancer Group Study No. 6European Urology, 2002
- DIETHYLSTILBESTEROL REVISITED: ANDROGEN DEPRIVATION, OSTEOPOROSIS AND PROSTATE CANCERJournal of Urology, 2002
- SAFETY AND EFFICACY OF AN IMPLANTABLE LEUPROLIDE DELIVERY SYSTEM IN PATIENTS WITH ADVANCED PROSTATE CANCERJournal of Urology, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Early Androgen Deprivation for Prostate Cancer?New England Journal of Medicine, 1999
- Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study GroupJAMA, 1991
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- KETOCONAZOLE THERAPY FOR ADVANCED PROSTATE CANCERThe Lancet, 1984
- Reconsideration of Orchiectomy in the Treatment of Advanced Prostatic CarcinomaSouthern Medical Journal, 1977